High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model
- 17 August 2000
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 19 (35) , 4011-4021
- https://doi.org/10.1038/sj.onc.1203732
Abstract
Analysis of the functions of AP-1 transcription factor in cellular systems has shown its key role as a mediator of oncogenic signals. The employment of suitable animal model systems greatly facilitates the study of changes in the composition and activity of the AP-1 complex. Here, we have analysed the quantitative and qualitative changes of AP-1 at different stages of carcinogenesis in mouse skin cell lines, derived from tumours induced by chemical mutagens. The findings of this study suggest that elevated AP-1 DNA binding and transactivation activity characterize the carcinoma cell lines, most notably the highly malignant spindle carcinomas. In addition, increased amounts and post-translational modifications of c-Jun, Fra-1, Fra-2 and ATF-2 proteins account for a high percentage of the increased AP-1 activity. Remarkably, high levels of phosphorylated ATF-2 protein were detected in malignant cell lines, indicating a novel role of ATF-2 in tumour progression. c-Jun and ATF-2 proteins are phosphorylated by highly active JNK kinases present in tumour cells. Finally, our results indicate distinct functions for different AP-1 components in the promotion and progression of mouse skin tumours.Keywords
This publication has 59 references indexed in Scilit:
- ATF-2 has intrinsic histone acetyltransferase activity which is modulated by phosphorylationNature, 2000
- Phosphorylation and high level expression of Fra-2 in v-src transformed cells: a pathway of activation of endogenous AP-1Oncogene, 1997
- Transformation by ras modifies AP1 composition and activityOncogene, 1997
- STATs: Signal Transducers and Activators of TranscriptionPublished by Elsevier ,1996
- Constitutive ap‐1 dna binding and transactivating ability of malignant but not benign mouse epidermal cellsMolecular Carcinogenesis, 1994
- Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumorsCell, 1993
- Comparison of ras activation during epidermal carcinogenesis in vitro and in vivoCarcinogenesis: Integrative Cancer Research, 1991
- Transformation suppressor activity of a Jun transcription factor lacking its activation domainNature, 1991
- Genetic changes in skin tumor progression: Correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7Cell, 1990
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976